Cabaletta Bio, Inc. (CABA) stock
CABANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.28−0.05 (-3.76%)
Close on Nov 13, 2026Market cap $217.02MP/E –Yield –
Cabaletta Bio price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Cabaletta Bio's price to book ratio was 2.7× on Apr 30, 2026, against 0.7× a year earlier. Over the last 5 years it ranged from 0.2× to 5.9×, with a median of 2.0×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Apr 30, 2026 | 2.7× | +1.2 |
| 2025 | Dec 31, 2025 | 1.5× | +0.9 |
| 2024 | Dec 31, 2024 | 0.6× | −5.2 |
| 2023 | Dec 29, 2023 | 5.9× | +2.8 |
| 2022 | Dec 30, 2022 | 3.1× | +2.2 |
| 2021 | Dec 31, 2021 | 0.9× | −1.7 |
| 2020 | Dec 31, 2020 | 2.6× | – |
See a number that looks wrong?